While hypophosphatemia has known adverse effects, including muscle cramping, weakness, respiratory depression, rhabdomyolysis, and osteomalacia (29), the clinical implications of low FGF-23 remain unclear. This evidence concerns the gene FGF23 and osteomalacia.